CNC.NYSECentene CORP

Form 4: Centene Director Boosts Stake with Significant Stock Purchase

Sentiment:

Insider Transaction Report


A director at Centene Corp. acquired 9,000 shares of common stock, signaling confidence in the company's future.

Better than expectedThe purchase of company stock by a director indicates strong confidence in the company's current valuation and future performance.

Summary

  • Theodore R. Samuels II, a Director of Centene Corp. (CNC), purchased 9,000 shares of common stock.
  • The transaction occurred on July 28, 2025, at a price of $27.62 per share.
  • Following this acquisition, Mr. Samuels' family trust beneficially owns 32,000 shares indirectly.
  • Additionally, Mr. Samuels directly owns 18,494.979 shares, which includes 3,579 restricted stock units subject to vesting requirements.
  • Mr. Samuels also holds 10,000 direct common stock options with an exercise price of $80.57, exercisable from February 7, 2025, and expiring on February 7, 2032.

Sentiment

Score: 8

Explanation: An insider purchase by a director is a strong positive signal, indicating confidence in the company's future and potentially its current valuation.

Positives

  • A director's purchase of company stock indicates confidence in the company's prospects and valuation.
  • The acquisition of 9,000 shares at $27.62 demonstrates a direct financial commitment by a key insider.

Negatives

  • No negative information is present in this Form 4 filing, as it primarily reports an insider purchase.

Risks

  • This filing does not contain information about company-specific risks; it is a transaction report.

Future Outlook

This Form 4 filing does not provide forward-looking statements or guidance regarding the company's future performance or strategic outlook, focusing solely on an insider transaction.

Industry Context

Insider purchases, particularly by directors, are often viewed positively by the market as they signal management's belief in the company's intrinsic value and future prospects, potentially indicating that the stock is undervalued relative to its peers in the healthcare services industry.

Related Party Transactions

  • The 32,000 shares are indirectly owned by a revocable family trust, of which Mr. Samuels serves as a co-trustee, indicating a related party beneficial ownership arrangement.

Stakeholder Impact

  • Shareholders may view this insider purchase as a positive signal, potentially increasing investor confidence and demand for the stock.
  • The transaction itself does not directly impact employees, customers, suppliers, or creditors.

Next Steps

  • This filing reports a completed transaction and does not outline specific future actions or milestones for the company or the reporting person beyond the ongoing vesting of restricted stock units.

Key Dates

DateDescription
02/07/2025Common Stock Option exercisable date
07/28/2025Date of common stock purchase transaction
07/29/2025Signature date of reporting person
02/07/2032Common Stock Option expiration date

Recommendation

buy

A director's decision to purchase a significant block of company stock at market price typically signals strong conviction in the company's future prospects and suggests the stock may be undervalued. This aligns management's interests with shareholders and often precedes positive performance, making it a 'buy' signal for investors.

Keywords

Centene Corp, CNC, Insider Trading, Form 4, Stock Purchase, Director, Theodore R. Samuels II, Equity Acquisition

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.